MedPath

Indiana University Foundation, Inc.

Indiana University Foundation, Inc. logo
🇺🇸United States
Ownership
Private
Established
1820-01-20
Employees
10K
Market Cap
-
Website
http://www.indiana.edu

The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate

Phase 4
Completed
Conditions
Chronic Kidney Disease
Interventions
First Posted Date
2010-07-15
Last Posted Date
2013-05-21
Lead Sponsor
Indiana University
Target Recruit Count
16
Registration Number
NCT01163162
Locations
🇺🇸

Roudebush VA Medical Center, Indianapolis, Indiana, United States

Calcium and Phosphorus Balance and Calcium Kinetics in Patients With Stage 3/4 Chronic Kidney Disease

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Interventions
Dietary Supplement: 1500 mg/d elemental calcium as calcium carbonate
Dietary Supplement: Placebo
First Posted Date
2010-07-13
Last Posted Date
2014-07-29
Lead Sponsor
Indiana University
Target Recruit Count
12
Registration Number
NCT01161407
Locations
🇺🇸

Indiana University Hospital - Clinical Research Center, Indianapolis, Indiana, United States

Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data

Completed
Conditions
Glaucoma
Interventions
Drug: (Cosopt®, prostaglandin)
First Posted Date
2010-06-17
Last Posted Date
2014-01-22
Lead Sponsor
Indiana University
Target Recruit Count
56
Registration Number
NCT01145898
Locations
🇺🇸

Indiana University School of Medicine, Department of Ophthalmology, Indianapolis, Indiana, United States

The Study of Ocular Hemodynamics With Glaucoma Progression

Completed
Conditions
Glaucoma
First Posted Date
2010-06-17
Last Posted Date
2017-03-07
Lead Sponsor
Indiana University
Target Recruit Count
123
Registration Number
NCT01145911
Locations
🇺🇸

Indiana University School of Medicine, Department of Ophthalmology, Indianapolis, Indiana, United States

Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP)

Not Applicable
Completed
Conditions
Conscious Sedation
Interventions
Other: Standard sedation regimen
First Posted Date
2010-06-14
Last Posted Date
2023-09-28
Lead Sponsor
Indiana University
Target Recruit Count
56
Registration Number
NCT01143766
Locations
🇺🇸

University Hospital, Indiana University Purdue University Indianapolis, Indianapolis, Indiana, United States

Trial of Provider-to-Patient Interactive Voice Response (IVR) Calls to Improve Weight Management in Community Health Centers (CHCs)

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: Provider Voice
Behavioral: Generic Voice
First Posted Date
2010-05-26
Last Posted Date
2013-04-02
Lead Sponsor
Indiana University
Target Recruit Count
1228
Registration Number
NCT01131143
Locations
🇺🇸

Indiana University Center on Aging Research-Regenstrief Institute, Indianapolis, Indiana, United States

Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry

Completed
Conditions
Hypoglycemia Hyperglycemia
First Posted Date
2010-05-05
Last Posted Date
2015-08-31
Lead Sponsor
Indiana University
Target Recruit Count
206
Registration Number
NCT01116674
Locations
🇺🇸

Children's Healthcare of Atlanta at Egleston - Pediatric Intensive Care Unit, Atlanta, Georgia, United States

🇺🇸

Medical Center of Central Georgia - Pediatric Intensive Care Unit, Macon, Georgia, United States

🇺🇸

Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit, Atlanta, Georgia, United States

Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial

Phase 3
Completed
Conditions
Pediatric Patient (1m-21y)
ICU Admission
Hyperglycemia
Interventions
Other: Active Glycemic Control Strict (80-140mg/dL) vs. Conservative (190-220mg/dL) (with or without Continuous Glucose Monitoring)
First Posted Date
2010-05-05
Last Posted Date
2015-08-31
Lead Sponsor
Indiana University
Target Recruit Count
153
Registration Number
NCT01116752
Locations
🇺🇸

Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States

Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy Volunteers

Not Applicable
Completed
Conditions
Efavirenz, Metabolism and Pharmacokinetics Changes
Interventions
First Posted Date
2010-04-15
Last Posted Date
2014-12-17
Lead Sponsor
Indiana University
Target Recruit Count
61
Registration Number
NCT01104376
Locations
🇺🇸

Indiana University, Indianapolis, Indiana, United States

Gene Expression Profiles in Healing and Non-Healing Wounds

Terminated
Conditions
Wounds and Injuries
First Posted Date
2010-04-12
Last Posted Date
2024-04-25
Lead Sponsor
Indiana University
Target Recruit Count
74
Registration Number
NCT01101854
Locations
🇺🇸

IU Health Methodist Hospital, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath